What IT Policies Are Required for FDA-Regulated Companies?

For FDA-regulated organizations, IT policies are more than best practices. Whether you’re a biotech startup preparing for your first audit or a mature organization operating under ongoing FDA oversight, well-defined IT policies are critical to protecting data integrity, patient safety, and regulatory standing.

The FDA’s expectations are defined across many different regulations such as 21 CFR Part 11, cGMP, GLP, and GCP. Auditors expect documented, enforced, and routinely reviewed policies that demonstrate control over systems and data.

Below are the core IT policies FDA-regulated companies should have in place.

Access Control & User Management Policy

This policy defines who is allowed to access company systems and data, and under what circumstances. From an FDA perspective, access control is about ensuring that only authorized individuals can view, change, or approve regulated information. When employees change roles or leave the company, their access must be adjusted or removed promptly. Regular reviews are necessary to confirm that access still matches job responsibilities. FDA auditors frequently flag access control weaknesses because inappropriate access can undermine data integrity and call the reliability of records into question.

Electronic Records & Electronic Signatures (21 CFR Part 11)

Any organization that uses electronic systems in place of paper records or handwritten signatures must ensure those systems meet the FDA’s requirements. These policies establish confidence that electronic records are trustworthy, traceable, and legally equivalent to paper. They address how systems are validated, how changes are tracked, how electronic signatures are protected, and how records are retained and retrieved. It’s important to remember that, using cloud platforms or third-party software does not transfer responsibility, the regulated company remains accountable for compliance, regardless of who hosts the system.

Data Integrity & Data Governance Policy

Data integrity policies exist to ensure that information used to support product quality, safety, and regulatory decisions is complete, accurate, and reliable throughout its lifecycle. FDA places significant emphasis on whether data can be trusted, not just whether it exists. This policy defines how data is created, reviewed, stored, protected, and preserved over time, and how unauthorized or undocumented changes are prevented. Weak data governance can invalidate studies, delay approvals, or trigger enforcement actions.

Change Management Policy

Change management policies control how updates to IT systems are planned, reviewed, tested, and approved. From the FDA’s perspective, even small system changes can introduce risk if they affect validated systems or regulated records. This policy ensures that changes are evaluated for impact, approved by the appropriate stakeholders, properly tested, and fully documented. Uncontrolled or undocumented changes are a common audit finding because they undermine confidence in system reliability and compliance.

Incident Response & Cybersecurity Policy

This policy defines how the organization prepares for and responds to security incidents, such as cyberattacks, data breaches, or system outages. FDA expects companies to demonstrate that they can quickly identify issues, contain damage, notify appropriate parties, and document what happened and how it was resolved. When cybersecurity incidents are poorly managed, they can quickly escalate into regulatory and quality issues, affecting both compliance status and patient safety.

Backup, Disaster Recovery & Business Continuity Policy

FDA auditors expect companies to prove that critical systems and data can be restored if something goes wrong. This policy outlines how often data is backed up, where it is stored, how quickly systems must be restored, and how recovery processes are tested. If regulated data cannot be recovered in a timely and reliable manner, FDA may consider it unusable or noncompliant.

Vendor & Third-Party Management Policy

Modern FDA-regulated companies rely heavily on vendors such as cloud providers, software platforms, and managed service partners. This policy ensures that third parties are properly evaluated, monitored, and held to clear security and compliance expectations. While services can be outsourced, regulatory responsibility cannot, the FDA holds the regulated company accountable for vendor failures. Effective vendor oversight is essential to managing compliance and cybersecurity risk.

IT Training & Security Awareness Policy

Policies and controls are only effective if employees understand their responsibilities. This policy ensures that staff receive appropriate training on systems, data handling, and security expectations, both when they join and on an ongoing basis. Training should reflect job roles and evolve as systems and regulations change. FDA recognizes that human error is a leading cause of compliance and security incidents, making training a critical risk-reduction measure.

Documentation Matters as Much as Technology

A common misconception is that purchasing compliant software automatically ensures compliance. In reality, FDA auditors focus heavily on documentation, enforcement, and evidence. Policies must be formally approved, kept up to date, and consistently followed in practice. Technology enables compliance, but documentation proves it. Without clear, current, and enforced policies, even the best systems can fail an inspection.

Not sure where to start? We library of policy templates for FDA-regulated companies is designed to help organizations establish a solid compliance foundation quickly and confidently. Contact us to learn more.